Earnings Per Share, Basic in USD/shares of GT Biopharma, Inc. from Q1 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
GT Biopharma, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q1 2012 to Q3 2025.
  • GT Biopharma, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.83 USD/shares, a 45.8% increase year-over-year.
  • GT Biopharma, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -3 USD/shares, a 55.9% increase year-over-year.
  • GT Biopharma, Inc. annual Earnings Per Share, Basic for 2024 was -6.94 USD/shares, a 23.1% decline from 2023.
  • GT Biopharma, Inc. annual Earnings Per Share, Basic for 2023 was -5.64 USD/shares, a 71.3% increase from 2022.
  • GT Biopharma, Inc. annual Earnings Per Share, Basic for 2022 was -19.7 USD/shares, a 854% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

GT Biopharma, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$3 -$1 +$0.70 +45.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 -$4 -$1 +$1.62 +74.7% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 -$5 $0 +$1.31 +79.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 -$6 -$2 +$0.57 +26.3% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-21
Q3 2024 -$7 -$2 +$0.24 +13.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 -$7 -$2 -$1 -45.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 -$7 -$2 -$1 -681% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 -$5 -$2 +$17.00 +88.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-21
Q3 2023 -$22 -$2 -$2 -705% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$21 -$1 -$1 -1390% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$19 $0 $0 -23.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$19 -$19 -$19 -21400% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $0 $0 $0 -29.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $0 $0 +$0.05 +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $0 $0 +$1.66 +90.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$2 $0.09 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-31
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$2 -$2 -9050% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $0 +$0.07 +77.8% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-15
Q1 2019 -$5 $0 +$0.11 +55% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$5 -$50.1M -$49.6M -10362% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-29
Q3 2018 $49.6M -$5 +$3.45 +42.3% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $49.6M $50.1M* +$49.6M Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $17.00 $0 +$26.20 +99.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$8 -$479K -$479K -403084% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 $479K -$8 -$8 -6369% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $479K $479K* +$479K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $92.00 -$26 -$27 -3238% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $119 $119 +$131 Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$11 $0.13 -$1 -81.7% Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-02-28
Q2 2016 -$10 $0.07 -$11 -99.4% Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-02-28
Q1 2016 $0 $0.84 +$9.45 Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-02-28
Q4 2015 -$8 -$12 Oct 1, 2015 Dec 31, 2015 10-K/A 2018-02-28
Q3 2015 $0.71 +$0.72 Jul 1, 2015 Sep 30, 2015 10-Q/A 2018-02-28
Q2 2015 $11.20 +$11.20 Apr 1, 2015 Jun 30, 2015 10-Q/A 2018-02-28
Q1 2015 -$9 -$9 Jan 1, 2015 Mar 31, 2015 10-Q/A 2018-02-28
Q3 2014 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $0 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $0 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q2 2013 $0 +$0.01 Apr 1, 2013 Jun 30, 2013 10-Q 2015-01-08
Q1 2013 $0 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2015-01-08
Q2 2012 $0 Apr 1, 2012 Jun 30, 2012 10-Q 2014-12-12
Q1 2012 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2014-12-10

GT Biopharma, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$7 -$1 -23.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-21
2023 -$6 +$14.00 +71.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-21
2022 -$20 -$18 -854% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 -$2 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2018 -$5 +$3.44 +40% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-29
2017 -$9 -$129 -107% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $120 +$129 Jan 1, 2016 Dec 31, 2016 10-K 2018-03-01
2015 -$9 Jan 1, 2015 Dec 31, 2015 10-K/A 2018-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.